| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 09/23/2010 | US20100240030 new method for qualitative and quantitative detection of short nucleic acid sequences of about 8-50 nucleotides in length |
| 09/23/2010 | US20100240025 Bacteriophage with Enhanced Lytic Activity |
| 09/23/2010 | US20100239617 Modified rsv f proteins and methods of their use |
| 09/23/2010 | US20100239610 Influenza virus-like particles (vlps) comprising hemagglutinin produced within a plant |
| 09/23/2010 | US20100239608 PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS |
| 09/23/2010 | US20100239594 Compositions and methods for production of immunoglobulins |
| 09/23/2010 | US20100239593 Rsv-specific binding molecules and means for producing them |
| 09/23/2010 | US20100239586 Procalin polypeptides, antigens, and methods of use |
| 09/23/2010 | US20100239583 Antibodies against flagellin and uses thereof |
| 09/23/2010 | US20100239581 Kidney disease targets and uses thereof |
| 09/23/2010 | US20100239579 CD47 Related Compositions and Methods for Treating Immunological Diseases and Disorders |
| 09/23/2010 | US20100239577 Anti-glypican-3 antibody having improved kinetics in plasma |
| 09/23/2010 | US20100239575 Anti-cd40 antibodies and uses thereof |
| 09/23/2010 | US20100239571 CD30 Binding Agents and Uses Thereof |
| 09/23/2010 | US20100239564 Novel human growth factors |
| 09/23/2010 | US20100239554 Extended recombinant polypeptides and compositions comprising same |
| 09/23/2010 | US20100239545 Transfection with nucleic acid; insertion |
| 09/23/2010 | US20100239504 Imaging nucleic acid binding proteins |
| 09/23/2010 | US20100239501 Gene sensitive to bone/joint disease and use thereof |
| 09/23/2010 | CA2755667A1 Protein production in microorganisms of the phylum labyrinthulomycota |
| 09/23/2010 | CA2755409A1 Treatment of nuclear factor (erythroid-derived 2)-like 2 (nrf2) related diseases by inhibition of natural antisense transcript to nrf2 |
| 09/23/2010 | CA2755404A1 Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1 |
| 09/22/2010 | EP2230304A1 RNAI modulation of RSV and therapeutic uses thereof |
| 09/22/2010 | EP2229956A1 Multimeric constructs |
| 09/22/2010 | EP1753866B1 Plastid transit peptides |
| 09/22/2010 | EP1554301B1 Dengue vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1 and 2. |
| 09/22/2010 | EP1401853B1 Modulators of pharmacological agents |
| 09/22/2010 | EP1368496B1 Method for alteration detection in nucleic acids |
| 09/22/2010 | CN101842381A Composition of asymmetric RNA duplex as microrna mimetic or inhibitor |
| 09/21/2010 | US7799912 Bifunctional chemical, preparation and use for detecting nucleic acid |
| 09/21/2010 | US7799906 DNA constructs comprising a first DNA segment that corresponds to at least a portion of a gene in the monolignol biosynthetic pathway, a spacer DNA segment, and a second DNA segment that is complementary to the first DNA segment; used to reduce or modulate the lignin content in plants |
| 09/21/2010 | US7799903 Nucleic acid-engineered materials |
| 09/21/2010 | US7799900 humanized and chimeric anti-CD20 antibodies for treatment of CD20 positive malignancies and autoimmune diseases; treatment of B-cell associated diseases |
| 09/21/2010 | US7799764 hypoxia-inducible factors (HIFs); modified antisense oligonucleotide that inhibits expression of human HIF-1 beta; cancer, eye disorders |
| 09/21/2010 | US7799759 albumin fusion proteins. Nucleic acid molecules encoding the albumin fusion proteins of the invention are also encompassed by the invention, as are vectors containing these nucleic acids, host cells transformed with these nucleic acids vectors, and methods of making the albumin fusion proteins |
| 09/21/2010 | US7799564 PUFA polyketide synthase systems and uses thereof |
| 09/21/2010 | US7799554 An analytical test for an analyte comprises a base with a reaction area and a visualization area, a capture species on the base in the visualization area comprising nucleic acid, and analysis chemistry reagents on the base in the reaction area |
| 09/21/2010 | US7799543 Human tumor necrosis factor receptor polynucleotides |
| 09/21/2010 | US7799541 for Systemic Inflammatory Response Syndrome (SIRS), including severe sepsis, septic shock and sepsis related to cardiac dysfunction |
| 09/21/2010 | US7799530 detecting specific single nucleotide polymorphisms (SNPs) in the human genome, and their association with acute coronary events and/or variability in the responsiveness to statin treatment (including preventive treatment) between different individuals; assessing for risk of heart disease |
| 09/21/2010 | US7799527 selecting a treatment for a desired synthesized polymer species; useful for automated selection of treatments for synthetic reaction products |
| 09/21/2010 | US7799523 Association of polymorphisms in the SOST gene region with bone mineral density |
| 09/21/2010 | US7799522 Specific double-stranded probes for homogeneous detection of nucleic acid and their application methods |
| 09/21/2010 | US7799330 comprises claimed amino acid sequence or an immunogenic fragment thereof wherein the protein elicits production of antibodies that interfere with invasion by Babesia bovis into erythrocytes |
| 09/21/2010 | CA2408746C Antisense phosporodiamidate morpholino oligonucleotide inhibition of cytochrome p450 to modulate drug pharmacokinetics |
| 09/21/2010 | CA2352082C Carriers for combinatorial compound libraries |
| 09/21/2010 | CA2290614C Process for the preparation of polymers having nucleobases as side groups |
| 09/21/2010 | CA2192694C Cloning and expression of an acetylcholine-gated ion channel receptor subunit |
| 09/21/2010 | CA2172145C Metal complexes with a charged linker |
| 09/16/2010 | WO2010105095A1 Engineering salt tolerance in photosynthetic microorganisms |
| 09/16/2010 | WO2010104596A1 Fluorobodies: intrinsically fluorescent binding ligands |
| 09/16/2010 | WO2010104192A1 Oligoamino sugar compound |
| 09/16/2010 | WO2010102372A1 Production process of high affinity and high specificity oligonucleotides for organic and inorganic molecules |
| 09/16/2010 | WO2010080129A3 Extended dicer substrate agents and methods for the specific inhibition of gene expression |
| 09/16/2010 | WO2010057203A3 Hdl particles for delivery of nucleic acids |
| 09/16/2010 | WO2010048228A3 Compositions and methods for inhibiting expression of transthyretin |
| 09/16/2010 | WO2006113246A3 Small activating rna molecules and methods of use |
| 09/16/2010 | US20100235951 Novel genes encoding insecticidal proteins |
| 09/16/2010 | US20100235948 Plants modified with mini-chromosomes |
| 09/16/2010 | US20100235947 Rice Pollen-Preferential Promoters And Uses Thereof |
| 09/16/2010 | US20100235946 Plant transcriptional factors as molecular markers |
| 09/16/2010 | US20100235944 Grain Quality Through Altered Expression of Seed Proteins |
| 09/16/2010 | US20100235941 F.oxysporum f.sp. melonis race 1,2-resistant melons |
| 09/16/2010 | US20100235934 Hydrocarbon-producing genes and methods of their use |
| 09/16/2010 | US20100235933 Kaspp (lrrk2) gene, its production and use for the detection and treatment of neurodegenerative disorders |
| 09/16/2010 | US20100234583 siRNA target hypoxia-inducible factor 1 |
| 09/16/2010 | US20100234582 siRNA targeting gremlin |
| 09/16/2010 | US20100234581 Thermostable xylose isomerase enzymes |
| 09/16/2010 | US20100234579 Silver nanoparticle binding agent conjugates based on moieties with triple cyclic disulfide anchoring groups |
| 09/16/2010 | US20100234528 Supports for oligomer synthesis |
| 09/16/2010 | US20100234450 Molecular targeting agents |
| 09/16/2010 | US20100234447 Modulation of glucagon receptor expression |
| 09/16/2010 | US20100234446 RNAi Modulation of the BCR-ABL Fusion Gene and Uses Thereof |
| 09/16/2010 | US20100234444 Hindered ester-based biodegradable linkers for oligonucleotide delivery |
| 09/16/2010 | US20100234300 A purified pro-cytolytic peptide; used to treat localized and metastatic prostate cancer; administered intratumorally and/or intraprostatically |
| 09/16/2010 | US20100234294 Identification of new isoforms of the mhc-class i specific receptor cd160 and uses thereof |
| 09/16/2010 | US20100234293 Novel Neurotrophic Factors |
| 09/16/2010 | US20100234290 Stabilized Insulin-like Growth Factor Polypeptides |
| 09/16/2010 | US20100234245 Primers and probes for the detection of streptococcus pneumoniae |
| 09/16/2010 | US20100234242 DNA Methylation Changes Associated with Major Psychosis |
| 09/16/2010 | US20100233804 Generation of pluripotent stem cells using recombinant proteins |
| 09/16/2010 | US20100233781 Tubular nanostructure targeted to cell membrane |
| 09/16/2010 | US20100233762 Thermostable y-family polymerases and chimeras |
| 09/16/2010 | US20100233760 Protein Production in Microorganisms of the Phylum Labyrinthulomycota |
| 09/16/2010 | US20100233757 Synthesis and Use of Anti-Reverse Phosphorothioate Analogs of the Messenger RNA Cap |
| 09/16/2010 | US20100233737 Marker specific to an oxidative degradation of tissues containing type iii collagen, means and methods and kits for the diagnosis, monitoring or prognosis of pathologies targeted by this marker |
| 09/16/2010 | US20100233726 Tandem fluorescent protein constructs |
| 09/16/2010 | US20100233717 Methods for detecting toxigenic microbes |
| 09/16/2010 | US20100233711 Gene encoding labyrinthin, a marker for cancer |
| 09/16/2010 | US20100233704 Methods of detecting lung cancer |
| 09/16/2010 | US20100233702 Method to predict response to treatment for psychiatric illnesses |
| 09/16/2010 | US20100233700 Ubiad1 gene and hyperlipidemia |
| 09/16/2010 | US20100233699 Primers and methods for the detection and discrimination of nucleic acids |
| 09/16/2010 | US20100233692 Fluorescently labeled fusion protein for assaying adenosine triphosphate |
| 09/16/2010 | US20100233684 Method for determining inflammatory disease |
| 09/16/2010 | US20100233680 Gene Expression Profiles and Methods of Use |
| 09/16/2010 | US20100233675 Analyte manipulation and detection |
| 09/16/2010 | US20100233209 Chikungunya virus infectious clones and uses therefor |
| 09/16/2010 | US20100233190 Targeted polymeric prodrugs containing multifunctional linkers |
| 09/16/2010 | US20100233186 Novel receptor that binds ctla-8 |